Drug Use Analysis of Postoperative Chemotherapy in Patients with Non-small Cell Lung Cancer / 中国药师
China Pharmacist
;
(12): 293-295, 2014.
Article
in Chinese
| WPRIM
| ID: wpr-452761
ABSTRACT
Objective:
To explore the drug application in the postoperative chemotherapy for the patients with non-small cell lung cancer.Methods:
The chemotherapy regimens, drug utilization and adverse drug reactions in the non-small cell lung cancer patients received postoperative chemotherapy in 2012 were statistically analyzed in a retrospective study.Results:
Totally 8 kinds of chemother-apy regimens were used in 156 cases. The NC( vinorelbine + carboplatin) regimen was used most frequently and the PC( pemetrexed+ carboplatin) regimen was with the highest expense. Proton pump inhibitors, recombinant human erythropoietin and lentinan were the top three in the adjuvant drugs used in the treatment.Conclusion:
It is necessary to further standardize the postoperative chemo-therapy for non-small cell lung cancer patients. Thoracic surgeons along with pharmacists should strengthen the drug use monitoring during the whole treatment process to promote the rational drug use.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Observational study
Language:
Chinese
Journal:
China Pharmacist
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS